Cord blood donations can save children’s lives

Blood from umbilical cords can treat a wide range of life-threatening illnesses in children, from leukemia to sickle cell disease. Cynthia L. Price, a WUSM pediatric research coordinator at St. Louis Children’s Hospital, describes the benefits of donating cord blood in the following St. Louis Post-Dispatch article.

Longevity protein may slow many neurodegenerative disorders

A protein linked to increased lifespan in yeast and worms can also delay the degeneration of ailing nerve cell branches, according to WUSTL researchers. Scientists report in the Aug. 13 issue of Science that their findings might open the door to new treatments for a wide range of neurodegenerative disorders, including Parkinson’s, Alzheimer’s and Lou Gehrig’s disease.

Peanut butter treatment nourishes starving children

ManaryMark Manary, a WUSM pediatrician at St. Louis Children’s Hospital, is saving the lives of children in Malawi with peanut butter. His revolutionary new method for treating starving children in malnourished regions could become a worldwide standard of care. Tina Hesman tells the story of Manary’s work in the following St. Louis Post-Dispatch article.

Nervous system ‘ears’ line up across from ‘mouths’

Neurons communicate at a synapseAs the nervous system develops early in life, it must create millions of synapses—small spaces between nerve cells across which the cells can communicate. Scientists have long speculated that these synapses are deliberately organized to place the structures that send messages on one cell directly across from the structures on another nearby nerve cell that receive those messages. School of Medicine researchers have provided the first experimental proof of this theory at the level of the nervous systems’ most fundamental unit: individual clusters of structures that send and receive signals.

Does enrolling in medicare HMOs affect mortality?

People who are enrolled in Medicare Choice HMO plans with drug coverage die at about the same rate as those in traditional fee-for-service Medicare plans, but mortality rates for those in Medicare HMO plans without drug coverage are substantially higher. That’s the conclusion of a recent study done by Gautam Gowrisankaran, Ph.D., an assistant professor of economics at the Olin School of Business of Washington University in St. Louis, with University of Minnesota colleague Robert J. Town. The researchers’ estimates imply that a 10-percentage point shift in coverage from fee-for-service to HMO plans without drug coverage could result in 51,000 additional deaths per year among the elderly.

Strep bacteria spreads infection via wasplike ‘stinger’

An electron micrograph of strep bacteria infecting muscle tissueMicrobiologists at the School of Medicine discovered that Strep A, the bacteria responsible for strep throat and other more serious disorders, has a wasplike “stinger” it uses to infect cells. Scientists had expected to find a random profusion of pumps for spraying infection-related compounds. The newly discovered, dedicated stinger could prove to be an easier target for new infection-preventing drugs.

Book offers tips on improving memory as we age

Joe Angeles / WUSTL PhotoA new book co-authored by a memory researcher at Washington University in St. Louis is one-stop shopping for all the questions we have about memory and how serious our lapses might be as we grow older. Mark A. McDaniel, Ph.D., professor of psychology in Arts & Sciences at WUSTL, says his book, Memory Fitness: A Guide for Successful Aging, relies on many rigorous academic studies but is written for the lay person. “Our mission is to give the general public a good idea of what they can reasonably expect from their memory capabilities as they age,” says McDaniel about the book he co-authored with Gilles O. Einstein, Ph.D., professor and chair of the psychology department at Furman University. “It also outlines some reasonable expectations about things people can do to perhaps increase their memory performances.”

Promising breast cancer drug enters final phase of trials

Ellis utilizes genetic analysis to guide cancer therapy.A new breast cancer drug that has shown promise fighting a particularly tough type of tumor may become a viable option for cancer patients. Matthew Ellis, a WUSTL physician at the Siteman Cancer Center, has studied the medication, Lapatinib, since it first showed promise against breast cancer tumors. He is now conducting the final phase of trials for the drug. KSDK reporter Kay Quinn provides more details in the following St. Louis Post-Dispatch article.
Older Stories